XBI $128 +2%
Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!
Covid Updates
BNTX +9% & PFE +1% Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine.
VIR +3% & GSK +1% Announce the Start of the EMA Rolling Review of VIR-7831 (sotrovimab) for the Early Treatment of COVID-19.
Pipeline Updates
VXRT +4% Vaxart Announces First Subject Enrolled in Phase 1b Norovirus Dose-Ranging Trial in Elderly Adults.
KMPH +7% Serdexmethylphenidate (SDX) Has Been Classified as a Schedule IV Controlled Substance by the DEA.
CCXI -62% Announces Results of FDA Advisory Committee Meeting on Avacopan in ANCA-Associated Vasculitis.